LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 20.68 | 27.76 | 711 | 1119 | 0.6354 | 0.8370 | MN20160318_Q01 | N10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 20.68 | 27.76 | 1690 | 1119 | 1.5103 | 1.1607 | MN20160318_Q01 | N10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 20.68 | 27.76 | 38 | 1119 | 0.0340 | 0.0607 | MN20160318_Q01 | N21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 20.68 | 27.76 | 1581 | 1119 | 1.4129 | 1.1339 | MN20160318_Q01 | N21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 22.39 | 27.76 | 92 | 1305 | 0.0705 | 0.2407 | MN20160318_Q01 | G22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 22.39 | 27.76 | 1448 | 1305 | 1.1090 | 1.0376 | MN20160318_Q01 | G22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 22.39 | 27.76 | 66 | 1305 | 0.0505 | 0.1687 | MN20160318_Q01 | J19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 22.39 | 27.76 | 1867 | 1305 | 1.4299 | 1.1330 | MN20160318_Q01 | J19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 22.39 | 27.76 | 1573 | 1305 | 1.2047 | 1.0682 | MN20160318_Q01 | N10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 22.39 | 27.76 | 1862 | 1305 | 1.4260 | 1.1319 | MN20160318_Q01 | N10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 22.39 | 27.76 | 46 | 1305 | 0.0352 | 0.0952 | MN20160318_Q01 | N21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 22.39 | 27.76 | 1701 | 1305 | 1.3027 | 1.0975 | MN20160318_Q01 | N21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 24.09 | 27.76 | 84 | 1461 | 0.0575 | 0.2137 | MN20160318_Q01 | G22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 24.09 | 27.76 | 1553 | 1461 | 1.0625 | 1.0213 | MN20160318_Q01 | G22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 24.09 | 27.76 | 75 | 1461 | 0.0513 | 0.1898 | MN20160318_Q01 | J19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 24.09 | 27.76 | 2002 | 1461 | 1.3697 | 1.1131 | MN20160318_Q01 | J19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 24.09 | 27.76 | 1781 | 1461 | 1.2185 | 1.0703 | MN20160318_Q01 | N10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 24.09 | 27.76 | 2021 | 1461 | 1.3827 | 1.1166 | MN20160318_Q01 | N10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 24.09 | 27.76 | 41 | 1461 | 0.0281 | 0.0706 | MN20160318_Q01 | N21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 24.09 | 27.76 | 1847 | 1461 | 1.2636 | 1.0835 | MN20160318_Q01 | N21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 25.79 | 27.76 | 103 | 1605 | 0.0642 | 0.2511 | MN20160318_Q01 | G22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 25.79 | 27.76 | 1710 | 1605 | 1.0653 | 1.0217 | MN20160318_Q01 | G22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 25.79 | 27.76 | 104 | 1605 | 0.0648 | 0.2531 | MN20160318_Q01 | J19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 25.79 | 27.76 | 2116 | 1605 | 1.3183 | 1.0967 | MN20160318_Q01 | J19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 25.79 | 27.76 | 1942 | 1605 | 1.2099 | 1.0662 | MN20160318_Q01 | N10 |